[go: up one dir, main page]

RS50781B - Derivati pirido (2,3-d) pirimidina, njihovo dobijanje, njihova primena u terapiji - Google Patents

Derivati pirido (2,3-d) pirimidina, njihovo dobijanje, njihova primena u terapiji

Info

Publication number
RS50781B
RS50781B RSP-2009/0225A RSP20090225A RS50781B RS 50781 B RS50781 B RS 50781B RS P20090225 A RSP20090225 A RS P20090225A RS 50781 B RS50781 B RS 50781B
Authority
RS
Serbia
Prior art keywords
tert
butyl
pyrido
pyrimidine
derivatives
Prior art date
Application number
RSP-2009/0225A
Other languages
English (en)
Inventor
Bernard Bourrie
Pierre Casellas
Pierre Perreaut
Claude Muneaux
Samir Jegham
Original Assignee
Sanofi-Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis
Publication of RS50781B publication Critical patent/RS50781B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Jedinjenje koje odgovara formuli : karkterističnoj po tome što Ar2 i R1 su redom :2,6-dihlorofenil i terc-butil ;ili 2-bromo-6-hlorofenil i terc-butil;ili 2,6-dihlorofenil i etil;ili 2,6-dibromofenil i terc-butil ;ili 2,6-dibromofenil i etil;ili 2,6-dihlorofenil i fenil;ili 3,5-dimetoksi-fenil i terc-butil ;ili fenil i terc-butil;ili 2,6-dimetilfenil i terc-butil;ili 2,6-difluorofenil i terc-butil ;ili 2,6-dihlorofenil i izo-propil.Prijava sadrži još 10 patentnih zahteva.
RSP-2009/0225A 2005-07-01 2006-06-29 Derivati pirido (2,3-d) pirimidina, njihovo dobijanje, njihova primena u terapiji RS50781B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0507032A FR2887882B1 (fr) 2005-07-01 2005-07-01 Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique
PCT/FR2006/001518 WO2007003765A1 (fr) 2005-07-01 2006-06-29 DERIVES DE PYRIDO[2,3-d]PYRIMIDINE, LEUR PREPARATION, LEUR APPLICATION EN THERAPEUTIQUE

Publications (1)

Publication Number Publication Date
RS50781B true RS50781B (sr) 2010-08-31

Family

ID=36096420

Family Applications (2)

Application Number Title Priority Date Filing Date
RS20140121A RS53211B (sr) 2005-07-01 2006-06-29 DERIVATI PIRIDO[2,3-d]PIRIMIDINA, NJIHOVO DOBIJANJE, NJIHOVA PRIMENA U TERAPIJI
RSP-2009/0225A RS50781B (sr) 2005-07-01 2006-06-29 Derivati pirido (2,3-d) pirimidina, njihovo dobijanje, njihova primena u terapiji

Family Applications Before (1)

Application Number Title Priority Date Filing Date
RS20140121A RS53211B (sr) 2005-07-01 2006-06-29 DERIVATI PIRIDO[2,3-d]PIRIMIDINA, NJIHOVO DOBIJANJE, NJIHOVA PRIMENA U TERAPIJI

Country Status (41)

Country Link
US (2) US7504406B2 (sr)
EP (2) EP1902054B1 (sr)
JP (1) JP4472009B2 (sr)
KR (1) KR101298344B1 (sr)
CN (2) CN102260258B (sr)
AR (1) AR054812A1 (sr)
AT (1) ATE423119T1 (sr)
AU (1) AU2006264801B2 (sr)
BR (1) BRPI0613020A2 (sr)
CA (1) CA2610794C (sr)
CR (1) CR9568A (sr)
CY (2) CY1110457T1 (sr)
DE (1) DE602006005246D1 (sr)
DK (2) DK1902054T3 (sr)
DO (1) DOP2006000145A (sr)
EA (1) EA014312B1 (sr)
EC (1) ECSP078011A (sr)
ES (2) ES2322101T3 (sr)
FR (1) FR2887882B1 (sr)
HK (1) HK1122797A1 (sr)
HR (2) HRP20090236T1 (sr)
IL (1) IL187900A0 (sr)
JO (1) JO2550B1 (sr)
MA (1) MA29561B1 (sr)
ME (1) ME01813B (sr)
MX (1) MX2007016239A (sr)
MY (1) MY143089A (sr)
NO (1) NO20080418L (sr)
NZ (1) NZ564072A (sr)
PA (1) PA8684801A1 (sr)
PE (1) PE20070139A1 (sr)
PL (2) PL1902054T3 (sr)
PT (2) PT1902054E (sr)
RS (2) RS53211B (sr)
SI (2) SI2020410T1 (sr)
TN (1) TNSN07440A1 (sr)
TW (1) TWI321566B (sr)
UA (1) UA92021C2 (sr)
UY (1) UY29645A1 (sr)
WO (1) WO2007003765A1 (sr)
ZA (1) ZA200711032B (sr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2873118B1 (fr) 2004-07-15 2007-11-23 Sanofi Synthelabo Derives de pyrido-pyrimidine, leur application en therapeutique
FR2887882B1 (fr) * 2005-07-01 2007-09-07 Sanofi Aventis Sa Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique
FR2896246B1 (fr) 2006-01-13 2008-08-15 Sanofi Aventis Sa Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique.
FR2910813B1 (fr) 2006-12-28 2009-02-06 Sanofi Aventis Sa Nouvelle utilisation therapeutique pour le traitement des leucemies
CA2739901A1 (en) 2008-10-17 2010-04-22 Akaal Pharma Pty Ltd S1p receptors modulators
EP2344484B1 (en) * 2008-10-17 2016-06-08 Akaal Pharma Pty Ltd S1p receptors modulators and use thereof
FR2948568B1 (fr) * 2009-07-30 2012-08-24 Sanofi Aventis Formulation pharmaceutique
CN103204827B (zh) * 2012-01-17 2014-12-03 上海科州药物研发有限公司 作为蛋白激酶抑制剂的苯并噻二唑化合物及其制备方法和用途
EP2638911A1 (en) 2012-03-14 2013-09-18 Sanofi Novel combinations for treating acute myeloid leukaemia or chronic myeloid leukaemia
CN103833771A (zh) * 2012-11-22 2014-06-04 天津滨江药物研发有限公司 作为蛋白激酶Mek抑制剂的苯并五元杂环化合物及其制备方法和用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1171218A (en) 1967-11-09 1969-11-19 Parke Davis & Co New Heterocyclic Amine Compounds and Methods for their Production
JPH04128276A (ja) 1990-09-19 1992-04-28 Pfizer Pharmaceut Co Ltd アミノベンゾサルタム誘導体およびその用途
IL115256A0 (en) 1994-11-14 1995-12-31 Warner Lambert Co 6-Aryl pyrido (2,3-d) pyrimidines and naphthyridines and their use
WO1996015128A2 (en) 1994-11-14 1996-05-23 Warner-Lambert Company 6-ARYL PYRIDO[2,3-d]PYRIMIDINES AND NAPHTHYRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION
US5620981A (en) 1995-05-03 1997-04-15 Warner-Lambert Company Pyrido [2,3-D]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation
IL117923A (en) 1995-05-03 2000-06-01 Warner Lambert Co Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds
YU50402A (sh) * 2000-01-25 2005-11-28 Warner-Lambert Company Pirido(2,3-d)pirimidin-2,7-diaminski inhibitori kinaze
CZ20022929A3 (cs) * 2000-03-06 2003-02-12 Warner-Lambert Company 5-Alkylpyrido[2,3-d]pyrimidinové inhibitory tyrosinových kinas
ES2311532T3 (es) 2000-08-04 2009-02-16 Warner-Lambert Company Llc 2-(4-pirdil)amino-6-dialcoxifenil-pirido(2.3-d)pirimidin-7-onas.
WO2003000011A2 (en) * 2001-06-21 2003-01-03 Ariad Pharmaceuticals, Inc. Novel pyridopyrimidines and uses thereof
AU2002952453A0 (en) * 2002-11-01 2002-11-21 Novogen Research Pty Ltd Aminated isoflavonoid derivatives and uses thereof
US20050009849A1 (en) 2003-01-03 2005-01-13 Veach Darren R. Pyridopyrimidine kinase inhibitors
TW200502236A (en) * 2003-03-28 2005-01-16 Hoffmann La Roche Novel pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents
WO2005105097A2 (en) 2004-04-28 2005-11-10 Gpc Biotech Ag Pyridopyrimidines for treating inflammatory and other diseases
FR2873118B1 (fr) 2004-07-15 2007-11-23 Sanofi Synthelabo Derives de pyrido-pyrimidine, leur application en therapeutique
FR2887882B1 (fr) * 2005-07-01 2007-09-07 Sanofi Aventis Sa Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique
FR2896246B1 (fr) 2006-01-13 2008-08-15 Sanofi Aventis Sa Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique.
US8338435B2 (en) * 2006-07-20 2012-12-25 Gilead Sciences, Inc. Substituted pyrido(3,2-D) pyrimidines and pharmaceutical compositions for treating viral infections

Also Published As

Publication number Publication date
EA200800223A1 (ru) 2008-06-30
DOP2006000145A (es) 2008-01-31
MA29561B1 (fr) 2008-06-02
EA014312B1 (ru) 2010-10-29
US7504406B2 (en) 2009-03-17
DK2020410T3 (en) 2014-03-24
TWI321566B (en) 2010-03-11
PL2020410T3 (pl) 2014-05-30
BRPI0613020A2 (pt) 2010-12-14
DE602006005246D1 (de) 2009-04-02
US8008310B2 (en) 2011-08-30
PT2020410E (pt) 2014-03-20
ZA200711032B (en) 2009-04-29
CN102260258A (zh) 2011-11-30
RS53211B (sr) 2014-08-29
US20090163522A1 (en) 2009-06-25
PT1902054E (pt) 2009-04-22
ME01813B (me) 2014-09-20
JP2008544975A (ja) 2008-12-11
SI2020410T1 (sl) 2014-04-30
PA8684801A1 (es) 2007-01-17
CN101213196B (zh) 2011-09-07
CA2610794A1 (fr) 2007-01-11
US20080176874A1 (en) 2008-07-24
CY1114989T1 (el) 2016-12-14
TNSN07440A1 (en) 2009-03-17
EP1902054B1 (fr) 2009-02-18
FR2887882B1 (fr) 2007-09-07
EP2020410B1 (fr) 2013-12-18
ATE423119T1 (de) 2009-03-15
IL187900A0 (en) 2008-03-20
AR054812A1 (es) 2007-07-18
ES2450067T3 (es) 2014-03-21
KR20080021714A (ko) 2008-03-07
PL1902054T3 (pl) 2009-07-31
JP4472009B2 (ja) 2010-06-02
HRP20140246T1 (hr) 2014-06-20
CA2610794C (fr) 2012-02-21
WO2007003765A1 (fr) 2007-01-11
SI1902054T1 (sl) 2009-06-30
UY29645A1 (es) 2007-01-31
EP2020410A1 (fr) 2009-02-04
ECSP078011A (es) 2008-01-23
NZ564072A (en) 2012-02-24
AU2006264801B2 (en) 2012-05-10
CN102260258B (zh) 2015-01-07
CN101213196A (zh) 2008-07-02
HK1122797A1 (en) 2009-05-29
NO20080418L (no) 2008-03-28
MX2007016239A (es) 2008-03-06
MY143089A (en) 2011-03-15
KR101298344B1 (ko) 2013-08-20
HRP20090236T1 (en) 2009-05-31
CY1110457T1 (el) 2015-04-29
EP1902054A1 (fr) 2008-03-26
AU2006264801A1 (en) 2007-01-11
JO2550B1 (en) 2010-09-05
UA92021C2 (ru) 2010-09-27
TW200745102A (en) 2007-12-16
PE20070139A1 (es) 2007-03-07
FR2887882A1 (fr) 2007-01-05
ES2322101T3 (es) 2009-06-16
DK1902054T3 (da) 2009-06-15
CR9568A (es) 2008-02-20

Similar Documents

Publication Publication Date Title
RS50781B (sr) Derivati pirido (2,3-d) pirimidina, njihovo dobijanje, njihova primena u terapiji
ATE508747T1 (de) C-kit kinase-hemmer
TW200642689A (en) Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
MY150661A (en) Pyridin-3-yl derivatives as immunomodulating agents
ATE369370T1 (de) Substituierte 2h-(1,2,4)triazolo(4,3-a)pyrazine als gsk-3-inhibitoren
MY149853A (en) Pyridin-4-yl derivatives as immunomodulating agents
EA200700192A1 (ru) Производные фталазина в качестве ингибиторов parp
MY140841A (en) Indozolone derivatives as 11b-hsd1 inhibitors
CY1107846T1 (el) Παραγωγα κιναζολινονης χρησιμα ως βανιλλοειδεις ανταγωνιστες
TW200612950A (en) Quinazolinedione derivatives as PARP inhibitors
MX2009002735A (es) Derivados de oxindol como agentes anticancerigenos.
NO20044995L (no) Heterosykliske forbindelser
TW200616978A (en) Quinazolinone derivatives as parp inhibitors
TW200612958A (en) Substituted imidazole derivatives
MY183039A (en) Pyridin-2-yl derivatives as immunomodulating agents
AP1564A (en) Piperazinyl sulfonic acid derivatives, their pharmaceutical compositions and methods of use.
WO2006065590A3 (en) Pyridine and pyrimidine antiviral compositions
NO20080110L (no) Benzimidazolderivativer som 5-HT6,5-HT24
ATE433969T1 (de) Pyrimidine verbindungen
ATE259813T1 (de) Triazolopyrimidinderivate
IL173629A0 (en) Imidazo(4,5-b) pyridine derivatives and pharmaceutical compositions containing the same
DK1742950T3 (da) Pyrazolo-[4,3-D]-pyrimidiner
TW200745053A (en) 9-Aminocarbonylsubstituted derivatives of glycylcyclines
TW200628153A (en) Novel compounds
ATE246174T1 (de) Tosylprolin-derivate als thymidylat-synthase inhibitoren